144 ·Filed Jun 25, 2026

VTRS

Viatris Inc
NEUTRAL
Impact 3/10
Horizondays Processed3mo ago SEC0001628280-26-045540
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

The proposed sale is small relative to Viatris's market cap and relates to shares acquired through compensation vesting, not open-market accumulation being unwound. This is likely a routine liquidity event. Monitor for actual execution on Form 4 filings, but the 144 alone does not warrant a directional trade.

DirectionNeutral
Confidencemedium
Horizondays
Final — all horizons settled through T+60d
VTRS ▲ +4.72% at T+60d
NEUTRAL call ✓ call won +4.72% · α vs SPY -1.39% · entry $16.33 → $17.10
Entry anchored
Jun 25, 03:59 PM ET
via exchange tick
T+1d
-0.61%
call -0.61% · α -2.26%
$16.23
settled 3mo ago
T+5d
+2.27%
call +2.27% · α +0.10%
$16.70
settled 3mo ago
T+20d
+5.82%
call +5.82% · α +4.56%
$17.28
settled 2mo ago
T+60d
+4.72%
call +4.72% · α -1.39%
$17.10
settled 11d ago

Price Chart

Loading chart...

Executive Summary

Viatris officer Paul Campbell filed a Form 144 notice of intent to sell 50,076 shares of common stock, with an approximate market value of $809,678 based on the filing date. The shares being sold were acquired through vesting of stock awards in March 2023 and March 2024, suggesting routine portfolio diversification rather than a discretionary bearish signal. However, the historical performance of prior VTRS reports shows a negative average T+20 return of -2.37% and a 33% win rate on 6 settled directional calls, indicating that past model reads on this ticker have not been predictive.

Key Facts

  • Form 144 filed June 25, 2026 by officer Paul Campbell for the sale of 50,076 shares.
  • Estimated dollar value of proposed sale: $809,677.94 at approximately $16.17/share.
  • Shares were acquired via vesting of stock awards on 03/04/2023 (361 shares) and 03/02/2024 (49,715 shares) as compensatory payments.
  • Broker for the proposed sale is Merrill Lynch.
  • Viatris has a market cap of $18.6B with 67% analyst bullish rating.

Financial Impact

Proposed sale of 50,076 shares (~$810K) represents about 0.004% of Viatris's $18.6B market cap — de minimis.

dilutioninsider holdings

Risk Factors

  • Form 144 is a notice of intent — the sale may not be executed, but its filing signals the insider considered selling.
  • The historical calibration panel shows an average net alpha of -0.02% at T+20 for this filing-type segment, suggesting limited edge from this filing alone.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
67% bullish (18 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001628280-26-045540
Document: 0001628280-26-045540-index.html0001628280-26-045540
Document: 0001628280-26-045540.txt0001628280-26-045540
12 reports for VTRS
Performance horizon
60% Hit rate 3 of 5 directional calls best @ T+60▲ +17.24%May 4, 2026
Filters
Rows
Reports for VTRS — sortable, filterable
TypeNow
Aug 6, 2026
8w ago
8-K
BULLISH ★ 7/10
$16.29 $16.94▲ +3.99%▲ +3.39%$17.60 (+8.04%)
Jun 25, 2026
14w ago
144
NEUTRAL ★ 3/10
$16.33 $17.28▲ +5.82%▲ +4.56%$17.60 (+7.78%)
Jun 18, 2026
15w ago
8-K
NEUTRAL ★ 3/10
$15.38 $17.29▲ +12.42%▲ +12.57%$17.60 (+14.43%)
Jun 15, 2026
15w ago
8-K
NEUTRAL ★ 3/10
$16.04 $16.31▲ +1.68%▲ +1.48%$17.60 (+9.73%)
May 13, 2026
20w ago
Court Ruling
BULLISH ★ 7/10
$17.37 $16.31▼ −6.10%▼ −5.49%$17.60 (+1.32%)
May 7, 2026
21w ago
8-K
BULLISH ★ 7/10
$17.39 $15.56▼ −10.52%▼ −13.66%$17.60 (+1.21%)
May 4, 2026
21w ago
8-K
NEUTRAL ★ 3/10
$15.52 $15.69▲ +1.10%▼ −3.86%$17.60 (+13.40%)
May 4, 2026
21w ago
Court Ruling
NEUTRAL ★ 2/10
$15.20 $15.69▲ +3.22%▼ −2.56%$17.60 (+15.79%)
May 4, 2026
21w ago
Court Ruling
BULLISH ★ 4/10
$15.20 $15.69▲ +3.22%▼ −2.56%$17.60 (+15.79%)
Apr 13, 2026
24w ago
Court Ruling
MIXED ★ 6/10
$13.83 $16.92▲ +22.34%▲ +14.59%$17.60 (+27.26%)
Showing 10 of 12

US Market Status

Market Closed — Opens Mon (65h 4m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access